Literature DB >> 2811953

Neurologic reactions after a therapeutic dose of mefloquine.

L C Patchen, C C Campbell, S B Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2811953     DOI: 10.1056/NEJM198911163212017

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  [Use-risk consideration of anti-infective agents from the point of view of the licensing authority].

Authors:  W Christ; B Esch
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Pharmacokinetics of mefloquine in the presence of primaquine.

Authors:  J Karbwang; K Na Bangchang; A Thanavibul; D J Back; D Bunnag
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Effect of ampicillin on mefloquine pharmacokinetics in Thai males.

Authors:  J Karbwang; K Na Bangchang; D J Back; D Bunnag
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Clearing the air on malaria.

Authors:  R Wittes
Journal:  CMAJ       Date:  1991-03-15       Impact factor: 8.262

5.  The effect of metoclopramide on mefloquine pharmacokinetics.

Authors:  K Na Bangchang; J Karbwang; D Bunnag; T Harinasuta; D J Back
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of mefloquine.

Authors:  J Karbwang; N J White
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 7.  Prevention of malaria.

Authors:  J S Keystone
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 8.  CNS adverse events associated with antimalarial agents. Fact or fiction?

Authors:  P A Phillips-Howard; F O ter Kuile
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

9.  Adverse reaction to mefloquine associated with ethanol ingestion.

Authors:  R C Wittes; R Saginur
Journal:  CMAJ       Date:  1995-02-15       Impact factor: 8.262

10.  Influence of hemodialysis on plasma concentration-time profiles of mefloquine in two patients with end-stage renal disease: a prophylactic drug monitoring study.

Authors:  C A Crevoisier; I Joseph; M Fischer; H Graf
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.